恩替卡韦治疗肺结核合并HBV携带者抗结核药物所致肝损伤临床初步研究

doi:10.3969/j.issn.1672-5069.2017.05.027

Abstract

LI Kui，Ｒan Renyu，Jiang Zicheng,et al.. Clinical observation of entecavir in prophylactic effect of antituberculosis-drug-induced hepatotoxicity in patients with chronic hepatitis B virus carrier and pulmonary tuberculosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 606-607.

References

[1] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2015年版）. 实用肝脏病杂志，2016，19（3）：Ⅴ-ⅩⅩⅢ.
[2] 中华医学会结核病学分会．肺结核诊断和治疗指南．中华结核和呼吸杂志，2001，24（2）：70-74.
[3] Elmorsy E，Attalla SM，Fikry E，et al. Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics. Hum Exp Toxicol，2016[ahead of print].
[4] Jeong I，Park JS，Cho YJ，et al. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels. J Korean Med Sci，2015，30（2）:167-172.
[5] Heinrich MM，Zembrzuski VM，Ota MM，et al. Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil. Tuberculosis （Edinb），2016，101:15-24.
[6] Ji GY，Wang Y，Wu SQ，et al. Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicityin a prospective study. Genet Mol Res，2016，5（3）[ahead of print].
[7] Gupta VH，Singh M，Amarapurkar DN，et al.　Association of GST null genotypes with anti-tuberculosis drug induced hepatotoxicity in Western Indian population. Ann Hepatol，2013，2（6）:959-965.
[10] de Castro L，do Brasil PE，Monteiro TP，et al. Can hepatitis B virus infection predict tuberculosis treatment liver toxicity Development of a preliminary prediction rule. Int J Tuberc Lung Dis，2010，14（3）:332-340.
[11] Wong WM，Wu PC，Yuen MF，et al. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology，2000，31（1）:201-206.
[12] Saha A，Shanthi FXM，Winston AB，et al. Prevalence of hepatotoxicity from antituberculosis therapy:A five-year experience from south India. J Prim Care Community Health，2016，7（3）:171-174.
[13] 朱育银，郑春玉，叶春娟，等．短程化疗中乙型肝炎病毒标志物阳性对肝功能影响及处理．中国防痨杂志，2004，26:50-52.
[14] 许东，赵满芝，孙登顺，等．87例肺结核合并HBV携带者患者抗结核治疗的回顾性分析. 中西医结合肝病杂志，2013，23（2）:112-113.
[15] Liu YM，Cheng YJ，Li YL，et al. Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis. Lung，2014，192（1）:205-210.
[16] Shang P，Xia Y，Liu F，et al. Incidence， clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury （ATLI） in China. PLoS One，2011，6（7）:e21836.
[17] Abera W，Cheneke W，Abebe G. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone，South Ethiopia:A cohort study. Int J Mycobacteriol， 2016，5（1）:14-20.
[18] 王晓丽，虞朝辉，陈韶华，等．药物性肝病临床特征及预后分析．中华内科杂志. 2008，47（5）:385-388.

[1]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[2]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[3]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[4]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[5]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[6]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[7]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[8]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[9]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[10]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[11]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[12]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[13]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[14]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[15]	Bai Yichun, Deng Jihong, Mei Xiaoping. Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.

Clinical observation of entecavir in prophylactic effect of antituberculosis-drug-induced hepatotoxicity in patients with chronic hepatitis B virus carrier and pulmonary tuberculosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments